Helius Medical Tech Analyst Ratings
Helius Medical Tech Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 12/20/2022 | 323.73% | Maxim Group | → $1 | Initiates Coverage On | → Buy |
| 08/23/2022 | 2018.64% | Roth Capital | → $5 | Initiates Coverage On | → Buy |
| 11/15/2021 | — | Noble Capital Markets | Downgrades | Outperform → Market Perform | |
| 03/24/2021 | 8374.58% | Noble Capital Markets | → $20 | Initiates Coverage On | → Outperform |
| 04/16/2019 | — | BTIG | Downgrades | Buy → Neutral | |
| 04/11/2019 | — | Oppenheimer | Downgrades | Outperform → Perform | |
| 03/06/2019 | — | Oppenheimer | Initiates Coverage On | → Outperform | |
| 11/20/2018 | 5832.2% | BTIG | → $14 | Upgrades | Neutral → Buy |
| 06/19/2018 | — | BTIG | Downgrades | Buy → Neutral | |
| 05/17/2018 | 5832.2% | BTIG | → $14 | Initiates Coverage On | → Buy |
| 日期 | 上/下行 | 分析師公司 | 价格目標變更 | 評級變更 | 上一頁/目前評分 |
|---|---|---|---|---|---|
| 12/20/2022 | 323.73% | 美心集團 | → 1 美元 | 啟動覆蓋範圍 | → 購買 |
| 08/23/2022 | 2018.64% | 羅斯資本 | → 5 美元 | 啟動覆蓋範圍 | → 購買 |
| 11/15/2021 | — | 貴族資本市場 | 降級 | 跑贏大市 → 市場表現 | |
| 03/24/2021 | 8374.58% | 貴族資本市場 | → 20 美元 | 啟動覆蓋範圍 | → 跑贏大市 |
| 2019 年 4 月 16 日 | — | BTIG | 降級 | 購買 → 中性 | |
| 04/11/2019 | — | 奧本海默 | 降級 | 跑贏大市 → 執行 | |
| 03/06/2019 | — | 奧本海默 | 啟動覆蓋範圍 | → 跑贏大市 | |
| 11/20/2018 | 5832.2% | BTIG | → 十四美元 | 升級 | 中性 → 購買 |
| 06/19/2018 | — | BTIG | 降級 | 購買 → 中性 | |
| 2018 年 5 月 17 日 | 5832.2% | BTIG | → 十四美元 | 啟動覆蓋範圍 | → 購買 |
What is the target price for Helius Medical Tech (HSDT)?
赫利斯醫療科技 (HSDT) 的目標價格是多少？
The latest price target for Helius Medical Tech (NASDAQ: HSDT) was reported by Maxim Group on December 20, 2022. The analyst firm set a price target for $1.00 expecting HSDT to rise to within 12 months (a possible 323.73% upside). 2 analyst firms have reported ratings in the last year.
美心集團於 2022 年 12 月 20 日公佈了赫利斯醫療技術（納斯達克股票代碼：HSDT）的最新價格目標。該分析師公司設定了 1.00 美元的價格目標，預計 HSDT 將在 12 個月內上升至（可能達到 323.73％ 的上行情況）。2 家分析師公司在去年報告了評級。
What is the most recent analyst rating for Helius Medical Tech (HSDT)?
赫利斯醫療科技 (HSDT) 的最新分析師評級為何？
The latest analyst rating for Helius Medical Tech (NASDAQ: HSDT) was provided by Maxim Group, and Helius Medical Tech initiated their buy rating.
赫利斯醫療科技（NASDAQ：HSDT）的最新分析師評級由美心集團提供，赫利斯醫療科技發起了買入評級。
When is the next analyst rating going to be posted or updated for Helius Medical Tech (HSDT)?
赫利斯醫療技術（HSDT）的下一個分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Helius Medical Tech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Helius Medical Tech was filed on December 20, 2022 so you should expect the next rating to be made available sometime around December 20, 2023.
分析師在進行了廣泛的研究後獲得了股票評級，其中包括通過公共財務報表，與 Helius 醫療技術的高管和客戶交談以及收聽盈利電話會議。大多數分析師每三個月這樣做一次，因此您應該每年每家公司獲得 4 個評級。赫利斯醫療技術的最後評級於 2022 年 12 月 20 日提交，因此您應該期望下一個評級將在 2023 年 12 月 20 日左右的某個時間提供。
Is the Analyst Rating Helius Medical Tech (HSDT) correct?
分析師評級赫利斯醫療技術（HSDT）是否正確？
While ratings are subjective and will change, the latest Helius Medical Tech (HSDT) rating was a initiated with a price target of $0.00 to $1.00. The current price Helius Medical Tech (HSDT) is trading at is $0.24, which is within the analyst's predicted range.
儘管評級是主觀的並且會發生變化，但最新的赫利斯醫療技術（HSDT）評級是啟動的，目標價格為 0.00 美元至 1.00 美元。當前價格赫利斯醫療技術（HSDT）的交易價格為 0.24 美元，該價格在分析師的預測範圍內。
譯文內容由第三人軟體翻譯。